Check out our most popular compounded medications! Get Started
Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1% Topical Gel is a semisolid prescription medication, dispensed through a pump for easy and precise application. It is used to treat various skin conditions such as rosacea, acne vulgaris, seborrheic dermatitis, perioral dermatitis, and folliculitis. The gel-like consistency allows for targeted treatment and effective absorption of active ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NY, NJ, NH, FL and ME.
Prescriber? Sign in or create an account for prescription details and order forms.
Bayview Pharmacy is pleased to present a specially compounded topical gel formulation of Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1%. This unique formulation is specifically designed to address various skin conditions such as acne, rosacea, and seborrheic dermatitis. The Azelaic Acid component, a naturally occurring dicarboxylic acid, possesses anti-inflammatory, anti-bacterial, and anti-keratinizing properties. Ivermectin, an anti-parasitic medication, has demonstrated efficacy in reducing inflammation and the number of acne lesions. Metronidazole, an antibiotic, has been successfully used to treat a range of skin conditions, including rosacea and seborrheic dermatitis.
This compounded formulation is a semisolid preparation dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment. The gel-like consistency allows for optimal absorption of the active ingredients. It is suitable for all skin types and is easy to apply. The combination of Azelaic Acid, Ivermectin, and Metronidazole in this formulation creates a synergistic effect. This formulation is safe, well-tolerated, and associated with minimal side effects.
If you have any queries about this formulation or wish to understand how it can assist in treating your specific skin condition, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to helping you find the most suitable treatment option tailored to your individual needs.
Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1% Topical Gel is a semisolid formulation designed for easy and precise application on the skin. It is dispensed through a pump mechanism, ensuring targeted treatment or absorption of active ingredients in a gel-like consistency. This formulation is primarily indicated for the treatment of inflammatory papules and pustules of mild to moderate rosacea, as well as inflammatory lesions of acne vulgaris.
Patients with known hypersensitivity to any of the components should refrain from using this formulation. Additionally, caution should be exercised when using this topical gel in conjunction with other topical medications due to the potential for additive or synergistic effects. It is particularly important to avoid using this gel with other topical preparations containing sulfur, resorcinol, or salicylic acid.
While systemic absorption of Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1% Topical Gel is minimal and unlikely to cause clinically significant interactions with other medications, caution is advised when administering this formulation with other medications known to have a narrow therapeutic index.
Both Ivermectin 1% and Metronidazole 1% components of this formulation may interact with certain medications, including anticoagulants, anticonvulsants, and certain antibiotics. Therefore, patients should be closely monitored for potential interactions and any changes in their medication regimen should be discussed with their healthcare provider.
If you have any questions about the interactions of Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1% Topical Gel, please do not hesitate to reach out for further information.
Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1% Topical Gel is a compounded medication designed to address various skin conditions such as acne, rosacea, and seborrheic dermatitis. This unique formulation combines the anti-inflammatory properties of Azelaic Acid, the anti-parasitic benefits of Ivermectin, and the antibiotic action of Metronidazole. Together, these active ingredients work synergistically to reduce inflammation, decrease bacterial presence, and limit sebum production, thereby alleviating the symptoms associated with these skin conditions.
Azelaic Acid is known for its ability to reduce redness and swelling. Ivermectin, on the other hand, is an anti-parasitic agent that helps control the bacterial population on the skin. Metronidazole, a potent antibiotic, further aids in reducing the number of bacteria on the skin. This combination of active ingredients targets the symptoms of various skin conditions, including redness, swelling, and inflammation, providing relief and promoting healthier skin.
When using this topical gel, it is crucial to adhere to the instructions provided by your healthcare provider. Typically, the medication should be applied to the affected skin area twice daily or as directed by your healthcare provider. It is important to avoid contact with the eyes, mouth, and other mucous membranes. In case of accidental contact, rinse the area thoroughly with water. Additionally, refrain from using other topical medications on the same skin area without consulting your healthcare provider, as this may increase the risk of side effects.
If you have any questions or concerns about using Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1% Topical Gel, do not hesitate to reach out to your healthcare provider.
Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1% Topical Gel is a versatile formulation that has been utilized off-label for the treatment of a wide range of skin conditions. These include, but are not limited to, erythema nodosum, hidradenitis suppurativa, and actinic keratosis.
Furthermore, this topical gel has been used to combat skin infections caused by bacteria, fungi, and parasites. It has shown efficacy in treating conditions such as scabies, lice, and tinea versicolor. The gel has also been used to alleviate skin inflammation resulting from contact dermatitis, atopic dermatitis, and seborrheic dermatitis.
In addition to these, the Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1% Topical Gel has been used to address skin discoloration issues caused by melasma, post-inflammatory hyperpigmentation, and lentigines. It has also been employed in the treatment of skin lesions caused by actinic keratosis, basal cell carcinoma, and squamous cell carcinoma.
If you have any queries regarding the use of Azelaic Acid 15%/Ivermectin 1%/Metronidazole 1% Topical Gel for any of these conditions, please do not hesitate to contact us. We are here to provide you with the necessary information and guidance.
This is a compounded formulation of three active ingredients: Azelaic Acid, Ivermectin, and Metronidazole. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
The pump mechanism facilitates easy and precise application of the gel on the skin.
The gel has a semisolid, gel-like consistency. This allows it to spread easily on the skin and be absorbed effectively.
The gel works by delivering the active ingredients directly to the affected area of the skin. The active ingredients then work to treat the condition for which it has been prescribed.
The active ingredients in this topical gel are Azelaic Acid (15%), Ivermectin (1%), and Metronidazole (1%).
This topical gel is used to treat a variety of skin conditions. However, the specific conditions it is used to treat will depend on the individual patient's needs and the prescribing doctor's discretion.
You should apply this topical gel as directed by your healthcare provider. Typically, it is applied to the affected area of the skin in the quantity prescribed by your doctor.
As with any medication, there may be side effects associated with this topical gel. If you experience any adverse reactions, you should contact your healthcare provider immediately.
Before using this topical gel with other skincare products, you should consult with your healthcare provider. They can provide guidance on whether it is safe to do so based on your specific circumstances.
This topical gel should be stored in a cool, dry place away from direct sunlight. Always ensure the cap is tightly closed after use to prevent the product from drying out.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NY, NJ, NH, FL, and ME. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
